Literature DB >> 2077856

Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.

R Juul1, L Edvinsson, T A Fredriksen, R Ekman, A O Brubakk, S E Gisvold.   

Abstract

NPY is a putative neurotransmitter mainly co-localized with noradrenaline in sympathetic fibers which innervate the cerebral vasculature. The origin of most of the perivascular NPY fibers seems to be in the superior cervical ganglion. To investigate involvement of Neuropeptide Y (NPY) mechanisms in subarachnoid haemorrhage (SAH), twenty patients with SAH were investigated. NPY-LI (-like immunoreactivity) levels in the external jugular vein were assessed using radioimmunoassay in blood samples collected post-operatively (or after SAH in non-surgical patients) on days 1,2,3, 5,7 and 9. These levels were compared with the clinical course and blood flow velocity changes monitored with ultrasonic Doppler equipment from both middle cerebral arteries (MCA) and both internal carotid arteries (ICA). Compared to NPY-LI levels in 14 controls (mean 116 +/- 3 pmol/1), increased levels (up to 253 pmol/l) and a close relationship between velocities and NPY-LI levels were found in a subpopulation of the SAH patients. When comparing the mean haemodynamic index (V MCA/ipsilateral V ICA) and mean NPY-LI levels in each of the 20 patients, a correlation of r = 0.75, p = 0.0001 was found. Increased NPY-LI were found (131 +/- 8 pmol/l) when simultaneous Doppler velocity recordings showed vasoconstriction (Haemodynamic index greater than 5) compared with samples taken when the haemodynamic index was less than 5, p less than 0.05. When MCA velocity exceeded 120 cm/sec. increased levels were found (129 +/- 9 pmol/l) compared with the conditions when MCA velocity was less than 120 cm/sec (113 +/- 5 pmol/l), p = 0.06. The results indicate a possible NPY involvement in cerebral vasoconstriction after SAH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2077856     DOI: 10.1007/BF01405783

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  45 in total

1.  Raised plasma endothelin in aneurysmal subarachnoid haemorrhage.

Authors:  H Masaoka; R Suzuki; Y Hirata; T Emori; F Marumo; K Hirakawa
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

2.  Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.

Authors:  C Han; P W Abel
Journal:  J Cardiovasc Pharmacol       Date:  1987-06       Impact factor: 3.105

3.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation.

Authors:  J McCulloch; R Uddman; T A Kingman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

5.  Neuropeptide Y and cerebral blood flow.

Authors:  U I Tuor; L Edvinsson; J McCulloch
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

6.  Effect of neonatal 6-hydroxydopamine treatment on experimental vasospasm following a subarachnoid hemorrhage in the rat.

Authors:  T J Delgado; M A Arbab; E Rosengren; N A Svendgaard
Journal:  J Cereb Blood Flow Metab       Date:  1987-06       Impact factor: 6.200

7.  Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound.

Authors:  A G Harders; J M Gilsbach
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115

8.  Cerebral vasospasm evaluated by transcranial ultrasound correlated with clinical grade and CT-visualized subarachnoid hemorrhage.

Authors:  R W Seiler; P Grolimund; R Aaslid; P Huber; H Nornes
Journal:  J Neurosurg       Date:  1986-04       Impact factor: 5.115

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology.

Authors:  L Edvinsson; R Ekman; I Jansen; A Ottosson; R Uddman
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

View more
  4 in total

Review 1.  Peptidergic innervation of the cerebral circulation. Role in subarachnoid hemorrhage in man.

Authors:  L Edvinsson; R Uddman; R Juul
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

2.  Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.

Authors:  R Juul; H Hara; S E Gisvold; A O Brubakk; T A Fredriksen; G Waldemar; J F Schmidt; R Ekman; L Edvinsson
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Effect of subarachnoid haemorrhage on trigeminovascular calcitonin-gene-related peptide and substance P of the rat dura mater versus cerebral vasculature.

Authors:  A G Arand; M Zuccarello; B A Skidmore; R J Berger; J T Keller
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  Endogenous calcitonin gene-related peptide in cerebrospinal fluid and early quality of life and mental health after good-grade spontaneous subarachnoid hemorrhage-a feasibility series.

Authors:  Elisabeth Bründl; Martin Proescholdt; Eva-Maria Störr; Petra Schödel; Sylvia Bele; Julius Höhne; Florian Zeman; Alexander Brawanski; Karl-Michael Schebesch
Journal:  Neurosurg Rev       Date:  2020-06-22       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.